We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+7.89%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$314B
AUM Growth
+$19.1B
(+6.5%)
Cap. Flow
+$92.3M
Cap. Flow
% of AUM
0.03%
Top 10 Holdings %
Top 10 Hldgs %
20.84%
Holding
3,440
New
118
Increased
1,247
Reduced
1,874
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$905M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$585M |
| 3 |
Cisco
CSCO
|
+$554M |
| 4 |
International Flavors & Fragrances
IFF
|
+$456M |
| 5 |
Mastercard
MA
|
+$392M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.37B |
| 2 |
DuPont de Nemours
DD
|
+$556M |
| 3 |
Qualcomm
QCOM
|
+$405M |
| 4 |
Merck
MRK
|
+$333M |
| 5 |
TSMC
TSM
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.31% |
| 2 | Consumer Discretionary | 12.98% |
| 3 | Financials | 12.81% |
| 4 | Healthcare | 12.54% |
| 5 | Communication Services | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITOS
2201
DELISTED
iTeos Therapeutics
ITOS
| $4.3M | ﹤0.01% |
125,772
+70,784
| +129% | +$2.56M |
|
2202
Hanmi Financial
HAFC
$946M
| $4.28M | ﹤0.01% |
217,030
+50,796
| +31% | +$824K |
|
2203
DMC Global
BOOM
$157M
| $4.28M | ﹤0.01% |
78,853
+2,151
| +3% | +$123K |
|
|
NTST
2204
NETSTREIT Corp
NTST
$2.1B
| $4.27M | ﹤0.01% |
230,939
-227,763
| -50% | -$4.06M |
|
2205
Alpha and Omega Semiconductor
AOSL
$1.08B
| $4.25M | ﹤0.01% |
129,978
+35,069
| +37% | +$1.15M |
|
2206
Anterix
ATEX
$1.94B
| $4.24M | ﹤0.01% |
89,942
+22,228
| +33% | +$915K |
|
2207
Funko
FNKO
$328M
| $4.23M | ﹤0.01% |
215,078
+109,082
| +103% | +$1.52M |
|
|
RUBY
2208
DELISTED
Rubius Therapeutics, Inc
RUBY
| $4.23M | ﹤0.01% |
159,493
-18,979
| -11% | -$277K |
|
|
ADVM
2209
DELISTED
Adverum Biotechnologies
ADVM
| $4.22M | ﹤0.01% |
42,850
+3,127
| +8% | +$375K |
|
2210
Alector
ALEC
$199M
| $4.2M | ﹤0.01% |
208,660
-4,051
| -2% | -$72.6K |
|
|
NP
2211
DELISTED
Neenah, Inc. Common Stock
NP
| $4.2M | ﹤0.01% |
81,702
-1,128
| -1% | -$62.7K |
|
2212
Enanta Pharmaceuticals
ENTA
$400M
| $4.19M | ﹤0.01% |
85,019
-2,454
| -3% | -$122K |
|
2213
Ocular Therapeutix
OCUL
$2.02B
| $4.18M | ﹤0.01% |
254,951
-345,720
| -58% | -$6.66M |
|
2214
Scorpio Tankers
STNG
$3.81B
| $4.18M | ﹤0.01% |
226,489
-3,332
| -1% | -$51.5K |
|
2215
Mesa Laboratories
MLAB
$574M
| $4.18M | ﹤0.01% |
17,166
-307
| -2% | -$84.5K |
|
2216
Liberty Global Class A
LBTYA
$3.6B
| $4.18M | ﹤0.01% |
162,867
-398,650
| -71% | -$10.1M |
|
|
CLR
2217
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $4.16M | ﹤0.01% |
160,730
-3,417
| -2% | -$80.1K |
|
|
AGR
2218
DELISTED
Avangrid, Inc.
AGR
| $4.13M | ﹤0.01% |
83,016
-72,104
| -46% | -$3.38M |
|
|
DOYU
2219
DouYu International Holdings
DOYU
$142M
| $4.13M | ﹤0.01% |
39,656
-5,860
| -13% | -$794K |
|
|
FRG
2220
DELISTED
Franchise Group, Inc.
FRG
| $4.12M | ﹤0.01% |
114,186
+15,544
| +16% | +$551K |
|
2221
Universal Electronics
UEIC
$61.3M
| $4.12M | ﹤0.01% |
74,964
-347
| -0.5% | -$20K |
|
|
EVOP
2222
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $4.11M | ﹤0.01% |
149,483
-13,839
| -8% | -$373K |
|
|
KBAL
2223
DELISTED
Kimball International
KBAL
| $4.11M | ﹤0.01% |
293,262
-23,099
| -7% | -$300K |
|
|
PETQ
2224
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $4.08M | ﹤0.01% |
115,581
+2,199
| +2% | +$77.8K |
|
|
CELL
2225
DELISTED
PhenomeX Inc. Common Stock
CELL
| $4.07M | ﹤0.01% |
81,119
-299,337
| -79% | -$20.4M |
|
Similar funds
VFT
Nuveen's Q1 2021 Portfolio in Review
As of Q1 2021, Nuveen held 3,440 positions worth $314B, up 6.5% from $295B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Nuveen's Q1 2021 filing shows 118 new, 1,247 increased, 1,874 reduced and 82 closed positions. Its largest new stake was Coupang: 6,313,287 shares worth $312M. The largest sale was Apple, an estimated $1.37B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- Nuveen's largest Q1 2021 buy was Coupang: 6,313,287 shares worth $312M.
- Nuveen added most to Intel in Q1 2021, an estimated $905M increase.
- Nuveen's biggest Q1 2021 reduction was Apple, cutting an estimated $1.37B.
- Nuveen fully exited PARSLEY ENERGY INC in Q1 2021, selling an estimated $122M.
- Nuveen's ten largest holdings make up 21% of its $314B portfolio in Q1 2021.
- Nuveen opened 118 new positions and closed 82 in Q1 2021.
- Nuveen's portfolio value rose 6.5% quarter-over-quarter to $314B.
Based on Nuveen's 13F filing for Q1 2021, filed 17 May 2021.